Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CTI BIOPHARMA CORP (CTI)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Product sales        4.13.5
    Other        53.312.6
Total revenues   [+]53.90.00.03.326.325.157.416.1
            Revenue growth   [+]  -100.0%-87.3%4.5%-56.2%256.2%-73.2%
Cost of goods sold  3.50.00.00.00.00.41.41.9
Gross profit  50.40.00.03.326.324.856.014.2
            Gross margin  93.5%  100.0%100.0%98.6%97.6%88.0%
Selling, general and administrative  84.856.217.619.222.131.445.354.0
Research and development  36.939.125.924.136.532.965.076.6
Equity in earnings          
Other operating expenses  8.5 4.2   -5.10.3
EBITDA   [+]-77.8-94.8-47.2-39.4-31.6-38.8-48.3-115.7
            EBITDA margin  -144.3%  -1177.0%-120.4%-154.3%-84.2%-717.8%
Depreciation and amortization  2.00.50.50.50.60.70.81.0
EBIT   [+]-79.8-95.3-47.8-39.9-32.2-39.5-49.2-116.7
            EBIT margin  -147.9%  -1193.3%-122.6%-157.2%-85.6%-723.9%
Non-recurring items     0.80.7   
Interest expense, net   [+]13.12.40.8-0.20.01.92.62.1
Other income (expense), net   [+]-0.1-0.2-3.90.53.50.6-1.2-2.0
Pre-tax income  -93.0-97.9-52.5-40.0-29.4-40.8-53.0-120.8
Income taxes  0.00.00.00.00.0-0.2-0.9-1.3
            Tax rate  0.0%0.0%0.0%0.0%0.1%0.4%1.8%1.1%
Minority interest     0.00.0-0.2-0.9-1.3
Net income  -93.0-97.9-52.5-40.0-29.4-45.0-52.0-122.6
            Net margin  -172.4%  -1196.4%-111.8%-179.0%-90.6%-760.9%
   
Basic EPS   [+]($0.81)($1.09)($0.74)($0.69)($0.52)($1.24)($1.86)($6.51)
Diluted EPS   [+]($0.81)($1.09)($0.74)($0.69)($0.52)($1.24)($1.86)($6.51)
   
Shares outstanding (basic)   [+]114.790.171.158.056.136.427.918.8
Shares outstanding (diluted)   [+]114.790.171.158.056.136.427.918.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy